| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |